探讨介入技术治疗缺血性脑血管疾病的近远期疗效和安全性
To explore the long-term efficacy and safety of interventional techniques in treating ischemic cerebrovascular diseases
ES评分 0
| DOI |
10.12208/j. ijim.20220033 |
| 刊名 |
International Journal of Internal Medicine
|
| 年，卷(期) |
2022, 3(2) |
| 作者 |
|
| 作者单位 |
西宁市第二人民医院 青海西宁 ;
|
| 摘要 |
分析介入技术用于缺血性脑血管疾病的价值。方法 对2020年6月-2022年5月本科接诊缺血性脑血管疾病病人（n=86）进行随机分组，试验和对照组各43人，前者采取介入技术，后者行常规治疗。对比不良事件等指标。结果 关于NIHSS评分，在治疗后1个月和12个月：试验组比对照组低（P＜0.05）。关于病变血管综合评分，在治疗后3d和12个月：试验组比对照组低（P＜0.05）。关于不良事件，试验组的发生率2.33%，和对照组16.28%相比更低（P＜0.05）。结论 缺血性脑血管疾病用介入技术，不良事件发生率更低，近远期疗效都更好。
|
| Abstract |
Objective To analyze the value of interventional technology for ischemic cerebrovascular diseases. Methods Patients with ischemic cerebrovascular disease (n=86) from June 2020 to May 2022 were randomized, with 43 patients each in the control group, with the former taking interventional technology and the latter taking conventional treatment.Contrast the adverse events and other indicators. Results Regarding the NIHSS score, at 1 month and 12 months after treatment: the test group was lower than the control group (P<0.05). Regarding the lesion vascular composite score, at 3d and 12 months after treatment: the test group was lower than the control group (P<0.05).Regarding adverse events, the incidence in the trial group was 2.33% and was lower than in 16.28% in the control group (P<0.05). Conclusion The ischemic cerebrovascular disease has lower incidence of adverse events and better efficacy in the long term.
|
| 关键词 |
介入技术；安全性；缺血性脑血管疾病；神经功能
|
| KeyWord |
Interventional technology; Safety; Ischemic cerebrovascular disease; Neurological function
|
| 基金项目 |
|
| 页码 |
16-18 |
杨永栋*.
探讨介入技术治疗缺血性脑血管疾病的近远期疗效和安全性 [J].
国际内科前沿杂志.
2022; 3; (2).
16 - 18.